131 related articles for article (PubMed ID: 37918781)
41. Using CT texture analysis to differentiate between peripheral lung cancer and pulmonary inflammatory pseudotumor.
Liu C; Ma C; Duan J; Qiu Q; Guo Y; Zhang Z; Yin Y
BMC Med Imaging; 2020 Jul; 20(1):75. PubMed ID: 32631330
[TBL] [Abstract][Full Text] [Related]
42. Maxillofacial Spindle Cell Sarcoma With Lung Metastases on FDG PET/CT Imaging.
Wu X; Zhang C; Huang Y; Wang H; Jiang L
Clin Nucl Med; 2018 Sep; 43(9):703-704. PubMed ID: 30015665
[TBL] [Abstract][Full Text] [Related]
43. The impact of
Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A
Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508
[TBL] [Abstract][Full Text] [Related]
44. Predictive Value of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Assessment of Occult Lymph Node Metastasis in Non-Small Cell Lung Cancer.
Seol HY; Kim YS; Kim SJ
Oncology; 2021; 99(2):96-104. PubMed ID: 32980838
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
46. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
47. Dual-time-point
Huang YE; Huang YJ; Ko M; Hsu CC; Chen CF
Ann Nucl Med; 2016 Nov; 30(9):652-658. PubMed ID: 27492555
[TBL] [Abstract][Full Text] [Related]
48. Present and future roles of FDG-PET/CT imaging in the management of lung cancer.
Kitajima K; Doi H; Kanda T; Yamane T; Tsujikawa T; Kaida H; Tamaki Y; Kuribayashi K
Jpn J Radiol; 2016 Jun; 34(6):387-99. PubMed ID: 27121156
[TBL] [Abstract][Full Text] [Related]
49.
Seth N; Seth I; Bulloch G; Siu AHY; Guo A; Chatterjee R; MacManus M; Donnan L
Pediatr Blood Cancer; 2022 Mar; 69(3):e29415. PubMed ID: 34709700
[TBL] [Abstract][Full Text] [Related]
50. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study.
Zhai X; Guo Y; Qian X
Med Sci Monit; 2020 Jun; 26():e922675. PubMed ID: 32483109
[TBL] [Abstract][Full Text] [Related]
51. [18F]FDG PET-CT findings in an unusual case of synchronous double primary lung cancer of different histologies.
Sharma P; Ghosh I
Nucl Med Rev Cent East Eur; 2021; 24(2):108-109. PubMed ID: 34382677
[TBL] [Abstract][Full Text] [Related]
52. A rare case of follicular dendritic cell sarcoma involving multiple bones.
Jiang L; Tan H; Wang W; Cheng Y; Shi H
Clin Nucl Med; 2013 Jul; 38(7):582-5. PubMed ID: 23640234
[TBL] [Abstract][Full Text] [Related]
53. Cytological features of inflammatory pseudotumor-like follicular dendritic cell sarcoma of spleen: A case report.
Hang JF; Wang LC; Lai CR
Diagn Cytopathol; 2017 Mar; 45(3):230-234. PubMed ID: 27775241
[TBL] [Abstract][Full Text] [Related]
54. Multimodality imaging of Epstein-Barr virus-associated inflammatory pseudotumor-like follicular dendritic cell tumor of the spleen: case report and literature review.
Bui PL; Vicens RA; Westin JR; Jensen CT
Clin Imaging; 2015; 39(3):525-8. PubMed ID: 25725946
[TBL] [Abstract][Full Text] [Related]
55. Diagnostic accuracy of 18F-FDG PET/CT for detecting synchronous advanced colorectal neoplasia in patients with gastric cancer.
Choi BW; Kim HW; Won KS; Song BI; Cho KB; Bae SU
Medicine (Baltimore); 2016 Sep; 95(36):e4741. PubMed ID: 27603371
[TBL] [Abstract][Full Text] [Related]
56. Inflammatory pseudotumor of the lung with high FDG uptake.
Huellner MW; Schwizer B; Burger I; Fengels I; Schläpfer R; Bussmann C; Strobel K
Clin Nucl Med; 2010 Sep; 35(9):722-3. PubMed ID: 20706053
[TBL] [Abstract][Full Text] [Related]
57. Predictive value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for PD-L1 expression in non-small cell lung cancer: A systematic review and meta-analysis.
Seol HY; Kim YS; Kim SJ
Thorac Cancer; 2020 Nov; 11(11):3260-3268. PubMed ID: 32951338
[TBL] [Abstract][Full Text] [Related]
58. Inflammatory myofibroblastic tumor: FDG PET/CT findings with pathologic correlation.
Dong A; Wang Y; Dong H; Gong J; Cheng C; Zuo C; Lu J
Clin Nucl Med; 2014 Feb; 39(2):113-21. PubMed ID: 23797227
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic Performance of PET or PET/CT with Different Radiotracers in Patients with Suspicious Lung Cancer or Pleural Tumours according to Published Meta-Analyses.
Lococo F; Muoio B; Chiappetta M; Nachira D; Petracca Ciavarella L; Margaritora S; Treglia G
Contrast Media Mol Imaging; 2020; 2020():5282698. PubMed ID: 32405280
[TBL] [Abstract][Full Text] [Related]
60. Noninferiority of
Dai D; Rollo FD; Bryant J; Kim EE
Contrast Media Mol Imaging; 2018; 2018():8969714. PubMed ID: 29736155
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]